Research map: A patient-driven agenda for liver cirrhosis research

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · 2026 · Related
  3. Global burden of liver disease: 2023 update · Harshad C. Devarbhavi · 2023 · 2217 citations · Cited by this paper
  4. Toward a CKLM framework for integrated clinical trial design · 2026 · Related
  5. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial · Ming Shi · 2021 · 162 citations · Cited by this paper
  6. Large language models for detecting colorectal polyps in endoscopic images—further research is required · 2026 · Related
  7. Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study · Manal F. Abdelmalek · 2023 · 110 citations · Cited by this paper
  8. USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · 2026 · Related
  9. A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis · Mary Eugenia Rinella · 2023 · 90 citations · Cited by this paper
  10. Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · 2026 · Related
  11. Simvastatin and Rifaximin in Decompensated Cirrhosis · Elisa Pose · 2025 · 45 citations · Cited by this paper
  12. Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · 2026 · Related
  13. Use of Isosorbide Dinitrate and Hydralazine in African-Americans With Heart Failure 9 Years After the African-American Heart Failure Trial · Keith C. Ferdinand · 2014 · 36 citations · Cited by this paper
  14. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · 2026 · Related
  15. No safe level of alcohol consumption – Implications for global health · Gautam Mehta · 2019 · 33 citations · Cited by this paper
  16. Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · 2026 · Related
  17. AlcoChange: A digital therapeutic for patients with alcohol-related liver disease · Gautam Mehta · 2023 · 14 citations · Cited by this paper
  18. Enhanced acetate uptake and metabolism in endothelial cells promote tumour angiogenesis and immunosuppression by increasing histone acetylation · 2026 · Related
  19. Trends in alcohol-specific deaths in England, 2001–22: an observational study · Melissa Oldham · 2025 · 14 citations · Cited by this paper
  20. Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis ( CALIBRE Trial) · Dhiraj Tripathi · 2025 · 11 citations · Cited by this paper
  21. From O’Shaughnessy to opportunity: innovating Hepatology Trials in the UK · Oliver D. Tavabie · 2024 · 3 citations · Cited by this paper
  22. A retrospective validation of a federated machine learning framework (Hepa-FedBoost) for improving liver cancer computed tomography diagnosis across heterogeneous hospital networks · Chengquan Li · 2025 · 2 citations · Cited by this paper
  23. Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK · Helen Crisp · 2024 · 1 citation · Cited by this paper
  24. The UK’s Health Data Research Service can unlock major public benefit—if grounded in real world care and internationally connected · Iain Edward Buchan · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)